Also, it is a pity that we did not explore the pathogenic role of some mutations in vivo and in vitro, and we intend to explore the role of mutations in the development of PCNSL, e.g., mutations of KMT2D and CDKN2A genes, in future studies. The gene discussed is KMT2D; the disease is primary central nervous system lymphoma.